In The News
Russia’s Methadone Ban Is Fueling an HIV Epidemic in Crimea
When Russia annexed Crimea in March 2014, the peninsula’s new leadership announced that OAT therapy would be banned.
Brazil must legalise drugs – its existing policy just destroys lives
For decades, Brazil has had the same drug policy approach. Police, weapons and numerous arrests. It does not take an expert to conclude the obvious: the strategy has failed.
Testing Hepatitis B and Hepatitis C
Can be the first step to accessing healthcare, treatment and support.
Heroin Assisted Treatment: the case for expanding uptake Dr Alex Wodak writes for the October 2017 IDHDP Newsletter
Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers The restrictions which many European countries impose on free/reimbursed access to hepatitis C virus (HCV) direct-acting antivirals (DAAs) are contrary to guidelines and undermine the World Health Organization (WHO) goal to eliminate HCV as a major public health concern, new research suggests.
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review Sharing of equipment used for injecting drug use (IDU) is a substantial cause of disease burden and a contributor to blood-borne virus transmission. We did a global multistage systematic review to identify the prevalence of IDU among people aged 15–64 years; sociodemographic characteristics of and risk factors for people who inject drugs (PWID); and the prevalence of HIV, hepatitis C virus (HCV), and hepatitis B virus (HBV) among PWID.